Related Experiment Videos
Local control for locally advanced breast cancer: many opinions, few facts
International Journal of Radiation Oncology, Biology, Physics
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A Modular Multi-Agent Reinforcement Learning Framework Guided by LLMs: Improving Quality and Efficiency of Treatment Planning in Lung Radiotherapy.
International journal of radiation oncology, biology, physics·2026
A combined dose and microdosimetric modeling framework incorporating volume effects correlates with tissue sparing in proton minibeam radiotherapy.
International journal of radiation oncology, biology, physics·2026
Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.
International journal of radiation oncology, biology, physics·2026
Clinical and Treatment Factors associated with Lymphopenia after Palliative Radiation Therapy in Cancer Patients.
International journal of radiation oncology, biology, physics·2026
Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy.
International journal of radiation oncology, biology, physics·2026
Reanalysis of Mechanism-Inspired Relative Biological Effectiveness Models Based on Track-structure Monte Carlo Simulation.
International journal of radiation oncology, biology, physics·2026